Cantor Adam J, Wang Jingyun, Li Shanshan, Neely Daniel E, Plager David A
Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, Indianapolis.
Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, Indianapolis; Salus University Pennsylvania College of Optometry, Elkins Park.
J AAPOS. 2018 Jun;22(3):188-191. doi: 10.1016/j.jaapos.2018.01.014. Epub 2018 Apr 27.
To report the long-term efficacy of endoscopic cyclophotocoagulation (ECP) in pediatric glaucoma following cataract surgery (GFCS).
ECP was performed on 35 eyes of 25 patients <16 years of age with GFCS. Patients were followed for a minimum of 2 years. Treatment failure was defined as consecutive postoperative intraocular pressure (IOP) of >24 mm Hg, alternative glaucoma procedure following ECP, or occurrence of visually significant complications. Analysis was performed to estimate risk factors for failure.
A total of 27 aphakic and 8 pseudophakic eyes were included. Pretreatment IOP averaged 33.9 ± 7.9 mm Hg. Final IOP after a mean follow-up period of 7.2 years was 18.9 ± 8.8 mm Hg (P < 0.001). The success rate was 54% (19/35 eyes). The failure rate was not increased in pseudophakic patients relative to aphakic patients. Patients with single ECP demonstrated preserved visual acuity from baseline to final follow-up.
In this patient cohort, with average follow-up period of 7.2 years, ECP was useful in the treatment of pediatric GFCS.
报告内镜睫状体光凝术(ECP)治疗白内障术后小儿青光眼(GFCS)的长期疗效。
对25例年龄小于16岁的GFCS患者的35只眼进行ECP治疗。患者至少随访2年。治疗失败定义为术后连续眼压(IOP)>24 mmHg、ECP术后进行其他青光眼手术或出现具有明显视觉影响的并发症。进行分析以评估失败的危险因素。
共纳入27只无晶状体眼和8只人工晶状体眼。治疗前平均眼压为33.9±7.9 mmHg。平均随访7.2年后的最终眼压为18.9±8.8 mmHg(P<0.001)。成功率为54%(19/35只眼)。人工晶状体眼患者的失败率相对于无晶状体眼患者并未增加。接受单次ECP治疗的患者从基线到最终随访时视力保持稳定。
在该患者队列中,平均随访7.2年,ECP对小儿GFCS的治疗有效。